New Key Statistics Module, Z-Score and F-Score
OTCPK:NURPF Key Ratios
| Market Cap $ M | 1,644.90 |
| Enterprise Value $ M | 1,492.80 |
| P/E(ttm) | 18.02 |
| PE Ratio without NRI | 18.02 |
| Forward PE Ratio | 38.91 |
| Price/Book | 13.67 |
| Price/Sales | 12.37 |
| Price/Free Cash Flow | 15.56 |
| Price/Owner Earnings | 18.02 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 155.00 |
| EPS (TTM) $ | 0.81 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 12.97 |
| EV-to-EBITDA | 12.97 |
| PEG | -- |
| Shares Outstanding M | 129.95 |
| Net Margin (%) | 67.73 |
| Operating Margin % | 85.90 |
| Pre-tax Margin (%) | 88.45 |
| Quick Ratio | 5.78 |
| Current Ratio | 5.78 |
| ROA % (ttm) | 121.22 |
| ROE % (ttm) | 139.29 |
| ROIC % (ttm) | 897.02 |
| Dividend Yield % | -- |
| Altman Z-Score | 44.33 |
NURPF Number of Guru Trades
NURPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:NURPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:NURPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Neuren Pharmaceuticals Ltd Insider Transactions
No Available Data
News about OTCPK:NURPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers